[Pharmacological profile and clinical trial results of a long-acting, once weekly human GLP-1 receptor agonist Dulaglutide (Genetical Recombination)].

Article Details

Citation

Copy to clipboard

Tamaki C, Takeuchi M, Iwamoto N, Glaesner W

[Pharmacological profile and clinical trial results of a long-acting, once weekly human GLP-1 receptor agonist Dulaglutide (Genetical Recombination)].

Nihon Yakurigaku Zasshi. 2015 Oct;146(4):215-24. doi: 10.1254/fpj.146.215.

PubMed ID

26656966 [ View in PubMed

]

Abstract

Not Available

DrugBank Data that Cites this Article

Drug Targets

Drug	Target	Kind	Organism	Pharmacological Action	Actions
Dulaglutide	Glucagon-like peptide 1 receptor	Protein	Humans	Yes	Agonist	Details